Stocks and Investing Stocks and Investing
Wed, January 16, 2019
Tue, January 15, 2019
Mon, January 14, 2019

Matthew Gillmor Upgraded (TDOC) to Buy and Held Target at $80 on, Jan 14th, 2019


Published on 2024-10-26 11:46:49 - WOPRAI, Matthew Gillmor
  Print publication without navigation


Matthew Gillmor of Baird, Upgraded "Teladoc Health, Inc." (TDOC) to Buy and Held Target at $80 on, Jan 14th, 2019.

Matthew has made no other calls on TDOC in the last 4 months.



There are 6 other peers that have a rating on TDOC. Out of the 6 peers that are also analyzing TDOC, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steven Halper of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $83 on, Friday, September 28th, 2018


These are the ratings of the 5 analyists that currently disagree with Matthew


  • Donald Hooker of "Keybanc" Maintained at Buy with Increased Target to $94 on, Friday, September 28th, 2018
  • Jamie Stockton of "Wells Fargo" Maintained at Buy with Increased Target to $92 on, Friday, September 28th, 2018
  • Mohan Naidu of "Oppenheimer" Maintained at Buy with Increased Target to $89 on, Friday, September 28th, 2018
  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $94 on, Friday, September 28th, 2018
  • Stephanie Demko of "Citigroup" Maintained at Strong Buy with Increased Target to $88 on, Friday, September 21st, 2018
Contributing Sources